XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
Article Information
vol. 27 no. 1 155-161
PubMed
Published By
Print ISSN
Online ISSN
History
- October 10, 2003
- May 30, 2003
- Published in print December 23, 2003.
Copyright & Usage
DIABETES CARE
Author Information
- Jarl S. Torgerson, MD, PHD1,
- Jonathan Hauptman, MD2,
- Mark N. Boldrin, MS2 and
- Lars Sjöström, MD, PHD1
- 1Department of Body Composition and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden
- 2Hoffmann-La Roche, Nutley, New Jersey
- Address correspondence and reprint requests to Professor Lars Sjöström, Department of Body Composition and Metabolism, Vita Stråket 15, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden. E-mail: lars.sjostrom{at}medfak.gu.se